Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Pathway Type:



Showing 124331 - 124340 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0144857

Pw146525 View Pathway

Iobitridol Drug Metabolism Action Pathway

Drug Action
  • Iobitridol

SMP0144471

Pw146139 View Pathway

Iocetamic acid Drug Metabolism Action Pathway

Drug Action
  • Iocetamic acid

SMP0174586

Pw176261 View Pathway

Iocetamic acid Predicted Metabolism Pathway

Metabolites of Iocetamic acid are predicted with biotransformer.
Metabolic
  • Heme
  • Iocetamic acid
  • Iocetamic acid PIS1M1
  • Iocetamic acid PIS1M2

SMP0144885

Pw146553 View Pathway

Iodide Drug Metabolism Action Pathway

Drug Action

SMP0144481

Pw146149 View Pathway

Iodide I-123 Drug Metabolism Action Pathway

Drug Action
  • Iodide I-123

SMP0144406

Pw146074 View Pathway

Iodide I-131 Drug Metabolism Action Pathway

Drug Action
  • Iodide I-131

SMP0143974

Pw145642 View Pathway

Iodine Drug Metabolism Action Pathway

Drug Action

SMP0144523

Pw146191 View Pathway

Iodine povacrylex Drug Metabolism Action Pathway

Drug Action
  • Iodine povacrylex

SMP0143901

Pw145569 View Pathway

Iodipamide Drug Metabolism Action Pathway

Drug Action

SMP0126892

Pw128506 View Pathway

Iodipamide Metabolism

Iodipamide is a contrast agent used in cholangiography and cholecystography. Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Iodipamide's primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts. iodipamide is carried to the liver where it is rapidly secreted. The contrast medium appears in the bile within 10 to 15 minutes after injection, thus permitting visualization of the hepatic and common bile ducts, even in cholecystectomized patients. The biliary ducts are readily visualized within about 25 minutes after administration, except in patients with impaired liver function. The gallbladder begins to fill within an hour after injection; maximum filling is reached after two to two and one-half hours. The contrast medium is finally eliminated in the feces without passing through the enterohepatic circulation, except for approximately 10 percent of the intravenously administered dose which is excreted through the kidneys.
Metabolic
Showing 124331 - 124340 of 132202 pathways